Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-metastatic Patients With Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Testing effectiveness (Phase 2)Study completedNCT00001193
What this trial is testing

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Study completedNCT00059943
What this trial is testing

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Who this might be right for
Breast CancerLung CancerProstate Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00087347
What this trial is testing

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Who this might be right for
Breast CancerProstate Cancer
Massachusetts General Hospital 14
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Early research (Phase 1)Ended earlyNCT03549000
What this trial is testing

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
Novartis Pharmaceuticals 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT01758445
What this trial is testing

Proton Radiation for Stage II/III Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmBreast Tumor+1 more
Proton Collaborative Group 220
Early research (Phase 1)UnknownNCT01880385
What this trial is testing

Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
Association Tunisienne de lutte Contre le Cancer 30
Not applicableUnknownNCT01295463
What this trial is testing

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Who this might be right for
Cancer
Institut Català d'Oncologia 96
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Not applicableStudy completedNCT01460186
What this trial is testing

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasis
Centre Leon Berard 1,000
Early research (Phase 1)Study completedNCT01862081
What this trial is testing

A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer

Who this might be right for
Breast Cancer, Non-small Lung Cancer
Genentech, Inc. 80
Early research (Phase 1)Study completedNCT02222922
What this trial is testing

PF-06647020 For Adult Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 138
Early research (Phase 1)Ended earlyNCT01296555
What this trial is testing

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Who this might be right for
Solid CancersNon-Hodgkin's Lymphoma
Genentech, Inc. 674
Next Page